COMPANY PRODUCTS DISTRIBUTORS CERTIFICATIONS CONTACT HOMEPAGE PRODUCTS INFECTIOUS DISEASES PREGNANCY MANAGEMENT Pregnancy Management GENETIC DISEASES Cardiovascular Diseases Haemochromatosis HLA Typing Pharmacogenomic Genetic Disease Other INFECTIOUS DISEASES Emerging & Tropical Infection Transplantation Panel Hepatitis Virus Respiratory Infection Sexually Transmitted Diseases Pregnancy Management Nosocomial Infections EXTRACTION SYSTEM Manual Extraction Automatic Extraction IMMUNOCROMATOGRAPHIC ASSAY Rapid Test Pregnancy Management Product Code CE Mark Description quanty Measles RT-06 48 Test quanty Rubella RT-39 RUO 48 Test Measles/Rubella RT-21 RUO 48 Test quanty TOXO RT-94 48 Tests -ON0318 © 2021 CLONIT srl Via Lombardia 6 27010 Siziano (PV) - ITA Capitale sociale - € 64.600,00 i.v. C.F. e P.IVA 09014480157 REA CCIAA Milano 1267649 Back to homepage Products Genetic Diseases Infectious Diseases Extraction System Immunocromatographic Assay Company Products Distributors Certifications Contact Privacy PolicyCookie Information

COMPANY PRODUCTS DISTRIBUTORS CERTIFICATIONS CONTACT HOMEPAGE PRODUCTS GENETIC DISEASES PHARMACOGENOMIC Pharmacogenomic GENETIC DISEASES Cardiovascular Diseases Haemochromatosis HLA Typing Pharmacogenomic Genetic Disease Other INFECTIOUS DISEASES Emerging & Tropical Infection Transplantation Panel Hepatitis Virus Respiratory Infection Sexually Transmitted Diseases Pregnancy Management Nosocomial Infections EXTRACTION SYSTEM Manual Extraction Automatic Extraction IMMUNOCROMATOGRAPHIC ASSAY Rapid Test Pharmacogenomic Warfarin is the treatment of choice in the management of venous thromboembolic disease. The wide interindividual variability in warfarin response is influenced by some genetic variants: in particular, a single nucleotide polymorphism (SNP) in the Vitamin K Epoxide Reductase Complex Subunit 1 (VKORC1) known as VKORC1 (1639G>A) that is an important determinant of the initial Warfarin dosage, and two SNPs found in the cytochrome P450 enzyme gene CYP2C9 known as CYP2C9*2 (C430T) and CYP2C9*3 (A1075C). Product Code CE Mark Description VKORC1 EER054050 50 Tests - 1639 G>A Available for QiaSymphony SP/AS - Ref: EER54032QS CYP2C9*2 EER055050 50 Tests - 430 C>T Available for QiaSymphony SP/AS - Ref: EER055032QS CYP2C9*3 EER056050 50 Tests - 1075 A>C Available for QiaSymphony SP/AS - Ref: EER056032QS © 2021 CLONIT srl Via Lombardia 6 27010 Siziano (PV) - ITA Capitale sociale - € 64.600,00 i.v. C.F. e P.IVA 09014480157 REA CCIAA Milano 1267649 Back to homepage Products Genetic Diseases Infectious Diseases Extraction System Immunocromatographic Assay Company Products Distributors Certifications Contact Privacy PolicyCookie Information